La Piedad Michoacán Mexico Virus V protein antagonizes type I interferon response by binding STAT2 protein and...

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• La Piedad Michoacán Mexico Virus (LPMV) causes significant disease burden in swine, including neurological and reproductive issues.
• Paramyxoviridae family viruses, like LPMV, are known to evade innate immune responses by targeting interferon (IFN) signaling pathways.
• The V protein is a common antagonist of IFN signaling in paramyxoviruses, but its role in LPMV was previously uncharacterized.

Purpose of the Study:

• To investigate the role of the LPMV-V protein in antagonizing the type I and type II interferon (IFN) signaling pathways.
• To identify the specific mechanism by which LPMV-V protein interacts with components of the IFN cascade.

Main Methods:

• Co-immunoprecipitation assays to assess the binding of LPMV-V protein to STAT2.
• Western blotting to analyze protein levels and phosphorylation status of STAT1 and STAT2.
• Reporter assays to evaluate the impact of LPMV-V on IFN-induced signaling.

Main Results:

• LPMV-V protein antagonizes type I but not type II IFN signaling.
• LPMV-V protein binds to STAT2, a crucial component of the type I IFN pathway.
• The C-terminal 18 amino acids of LPMV-V are essential for STAT2 binding in both human and swine cells.
• LPMV-V inhibits the phosphorylation and nuclear translocation of STAT1 and STAT2, thereby blocking cellular responses to IFN α/β.

Conclusions:

• The LPMV-V protein acts as an antagonist of the type I interferon response by directly binding to STAT2.
• This interaction prevents the activation of STAT1 and STAT2, crucial for antiviral defense, thus contributing to LPMV's pathogenicity in swine.
• Understanding this mechanism provides insights into viral immune evasion strategies and potential targets for therapeutic interventions.